Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Siglyn M 50/1000 Tablet PR

Prescription Icon
Prescription Required

Marketer

Zydus Healthcare Limited

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Siglyn M 50/1000 Tablet PR

Duo-Med 50/1000 tablets effectively manage elevated blood glucose in individuals with type 2 diabetes, thus mitigating the risk of serious diabetic complications like renal impairment and vision loss. It may also lessen the likelihood of cardiovascular events. This medication might be prescribed independently or in conjunction with other anti-diabetic therapies. Optimal efficacy is achieved when combined with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glycemic control, and concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing, at the same time, maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Adherence to your physician's dietary and exercise plan is crucial. Lifestyle choices significantly influence diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal distress, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; appropriate management strategies should be learned. This medication isn't suitable for all patients. Prior to commencement, inform your doctor of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption. Pregnant or lactating women require medical consultation before use. Drug interactions are possible; disclose all medications to your physician to ensure treatment safety. Alcohol should be limited due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose levels throughout treatment.

Uses of Siglyn M 50/1000 Tablet PR

Managing type 2 diabetes

Major Benefits of Siglyn M 50/1000 Tablet PR:

Follow your doctor's instructions or the package leaflet for proper administration. Take Siglyn M 50/1000 Tablet PR with a meal.

Common Side effects of Siglyn M 50/1000 Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siglyn M 50/1000 Tablet PR:

Follow your doctor's instructions or refer to the product label for guidance. Take Siglyn M 50/1000 Tablet PR with food.

How Siglyn M 50/1000 Tablet PR works:

Siglyn M 50/1000 tablets are a dual-action formulation combining sitagliptin and metformin. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose generation, slows intestinal glucose absorption, and augments insulin sensitivity. This synergistic action leads to superior blood glucose management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Siglyn M 50/1000 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Siglyn M 50/1000 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Siglyn M 50/1000 tablets while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Siglyn M 50/1000 Tablet PR, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Siglyn M 50/1000 Tablet PR, as its use may be unsafe. Medical advice is recommended.

What if you forget to take Siglyn M 50/1000 Tablet PR :

Should you forget a dose of Siglyn M 50/1000 Tablet PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Siglyn M 50/1000 Tablet PR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Siglyn M 50/1000 Tablet PR

Siglyn M 50/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Siglyn M 50/1000 Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Siglyn M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Siglyn M 50/1000 Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol with Siglyn M 50/1000 Tablet PR is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (like Siglyn M 50/1000) can cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also known as MALA—Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siglyn M 50/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Siglyn M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Siglyn M 50/1000 Tablet PR components or excipients should not use it. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Siglyn M 50/1000 tablets is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M 50/1000) can cause lactic acidosis, a serious medical emergency involving excessive blood lactic acid (also called MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siglyn M 50/1000 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions provided. Discard any unused medication and keep it out of reach of children, pets, and others.
Siglyn M 50/1000 Tablet PR combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Siglyn M 50/1000 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Siglyn M 50/1000 Tablet PR is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Siglyn M 50/1000 Tablet PR is unsafe due to the increased risk of lactic acidosis.
Sitagliptin/Metformin (like Siglyn M 50/1000) can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siglyn M 50/1000 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Siglyn M 50/1000 Tablet P...
143